Abnormalities of Endothelial Function in Patients with Predialysis Renal Failure

Overview

Journal Heart

Date 2000 Jan 29

PMID 10648498

Citations 59

Authors

J Thambyrajah

M J Landray

F J McGlynn

H J Jones

D C Wheeler

J N Townend

Affiliations

Soon will be listed here.

Abstract

Background: Endothelial dysfunction plays an important role in the development of atherosclerotic vascular disease, which is the leading cause of mortality in patients with chronic renal failure.

Objective: To examine the relation between predialysis renal failure and endothelial function.

Design: Two groups were studied: 80 patients with non-diabetic chronic renal failure and 26 healthy controls, with similar age and sex distributions. Two indices of endothelial function were assessed: high resolution ultrasonography to measure flow mediated endothelium dependent dilatation of the brachial artery following reactive hyperaemia, and plasma concentration of von Willebrand factor. Endothelium independent dilatation was also assessed following sublingual glyceryl trinitrate. The patients were divided into those with and without overt atherosclerotic vascular disease.

Results: Although patients with chronic renal failure had significantly impaired endothelium dependent dilatation compared with controls (median (interquartile range), 2.6% (0.7% to 4.8%) v 6.5% (4.8% to 8.3%); p < 0.001) and increased von Willebrand factor (254 (207 to 294) v 106 (87 to 138) iu/dl; p < 0.001), there was no difference between renal failure patients with and without atherosclerotic vascular disease. Within the chronic renal failure group, endothelium dependent dilatation and von Willebrand factor were similar in patients in the upper and lower quartiles of glomerular filtration rate (2.7% (0.7% to 6.7%) v 2.8% (1.1% to 5.0%); and 255 (205 to 291) v 254 (209 to 292) iu/dl, respectively). Endothelium independent dilatation did not differ between the renal failure or control groups and was also similar in patients with renal failure irrespective of the degree of renal failure or the presence of atherosclerotic vascular disease.

Conclusions: Endothelial function is abnormal in chronic renal failure, even in patients with mild renal insufficiency and those without atherosclerotic vascular disease, suggesting that uraemia may directly promote the development of atherosclerosis early in the progression of chronic renal failure.

Citing Articles

Kidney transplantation in the presence of pulmonary hypertension: A clinical dilemma.

Farshbafnadi M, Ghannadzadeh Kermani Pour R, Sattarzadeh Badkoubeh R, Geraiely B, Mehrpooya M, Larti F Heliyon. 2024; 10(20):e39074.

PMID: 39640609 PMC: 11620137. DOI: 10.1016/j.heliyon.2024.e39074.

Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications.

Palomo M, Moreno-Castano A, Salas M, Escribano-Serrat S, Rovira M, Guillen-Olmos E Front Med (Lausanne). 2023; 10:1285898.

PMID: 38034541 PMC: 10682735. DOI: 10.3389/fmed.2023.1285898.

Endothelial function assessment by flow-mediated dilation of the brachial artery in acute kidney injury and chronic kidney disease.

Ramezanzadeh E, Arzpeyma S, Vakilpour A, Abedi M, Hassanipour S Caspian J Intern Med. 2023; 14(4):668-675.

PMID: 38024183 PMC: 10646350. DOI: 10.22088/cjim.14.4.668.

Pulmonary Manifestations at Different Stages in the Chronic Kidney Disease: An Observational Study.

Parivakkam Mani A, K S, Sundar R, Yadav S Cureus. 2023; 15(5):e39235.

PMID: 37337495 PMC: 10277162. DOI: 10.7759/cureus.39235.

Hypertension in chronic kidney disease: What lies behind the scene.

Ameer O Front Pharmacol. 2022; 13:949260.

PMID: 36304157 PMC: 9592701. DOI: 10.3389/fphar.2022.949260.

References

van Guldener C, Lambert J, Janssen M, Donker A, Stehouwer C . Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant. 1997; 12 Suppl 2:14-8. View

Kari J, Donald A, Vallance D, Bruckdorfer K, Leone A, Mullen M . Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 1997; 52(2):468-72. DOI: 10.1038/ki.1997.354. View

van Guldener C, Janssen M, Lambert J, Ter Wee P, Jakobs C, Donker A . No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. Nephrol Dial Transplant. 1998; 13(1):106-12. DOI: 10.1093/ndt/13.1.106. View

Boneu B, Abbal M, Plante J, BIERME R . Letter: Factor-VIII complex and endothelial damage. Lancet. 1975; 1(7922):1430. DOI: 10.1016/s0140-6736(75)92650-1. View

Cockcroft D, GAULT M . Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16(1):31-41. DOI: 10.1159/000180580. View

Murad F, Arnold W, Mittal C, Braughler J . Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. Adv Cyclic Nucleotide Res. 1979; 11:175-204. View

Harrison D, Armstrong M, Freiman P, Heistad D . Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987; 80(6):1808-11. PMC: 442458. DOI: 10.1172/JCI113276. View

McLenachan J, Vita J, Fish D, Treasure C, Cox D, Ganz P . Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation. 1990; 82(4):1169-73. DOI: 10.1161/01.cir.82.4.1169. View

Sadler J . von Willebrand factor. J Biol Chem. 1991; 266(34):22777-80. View

10.

Chin J, Azhar S, Hoffman B . Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1992; 89(1):10-8. PMC: 442813. DOI: 10.1172/JCI115549. View

11.

Vallance P, Leone A, Calver A, Collier J, Moncada S . Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992; 339(8793):572-5. DOI: 10.1016/0140-6736(92)90865-z. View

12.

Celermajer D, Sorensen K, Gooch V, Spiegelhalter D, Miller O, Sullivan I . Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340(8828):1111-5. DOI: 10.1016/0140-6736(92)93147-f. View

13.

Stamler J, Osborne J, Jaraki O, Rabbani L, Mullins M, Singel D . Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993; 91(1):308-18. PMC: 330028. DOI: 10.1172/JCI116187. View

14.

Raine A, Margreiter R, Brunner F, Ehrich J, Geerlings W, Landais P . Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant. 1992; 7 Suppl 2:7-35. View

15.

Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362(6423):801-9. DOI: 10.1038/362801a0. View

16.

Celermajer D, Sorensen K, Bull C, Robinson J, Deanfield J . Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994; 24(6):1468-74. DOI: 10.1016/0735-1097(94)90141-4. View

17.

Meade T, Cooper J, Stirling Y, Howarth D, Ruddock V, Miller G . Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994; 88(3):601-7. DOI: 10.1111/j.1365-2141.1994.tb05079.x. View

18.

Takagi M, Wada H, Mukai K, Kihira H, Yano S, Minamikawa K . Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis. Blood Coagul Fibrinolysis. 1994; 5(5):713-7. DOI: 10.1097/00001721-199410000-00006. View

19.

Joannides R, Haefeli W, Linder L, Richard V, Bakkali E, Thuillez C . Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995; 91(5):1314-9. DOI: 10.1161/01.cir.91.5.1314. View

20.

Haaber A, Eidemak I, Jensen T, Feldt-Rasmussen B, Strandgaard S . Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure. J Am Soc Nephrol. 1995; 5(8):1581-4. DOI: 10.1681/ASN.V581581. View